Philippe Moingeon

UNVERSITE PARIS SACLAY

Professeur, IA en santé

Description

"Philippe Moingeon is a pharmacist, a graduate of the University of Rouen, a former resident at the Hospitals of Paris, and holds a PhD in Immunology (University of Paris XI). He was a postdoctoral researcher and then Assistant Professor at Harvard Medical School (Boston, USA) and holds an MBA in Technology Management. He has over 30 years of experience in the pharmaceutical industry in the development of chemical and biological drugs, as Director of the cancer vaccine program and Secretary General of Research and Development at Aventis Pasteur, and later as Vice President of Pharmaceutical Research and Development at Stallergenes. He has registered two drugs and is the author of 240 scientific publications (H Index 65) and 23 patents. He joined Servier in 2017 to lead the Immuno-inflammation therapeutic area, where he explored the applications of artificial intelligence in the design of new drugs for diseases of the immune system. He is currently an Associate Professor of AI in Health at Paris-Saclay University and a member of the French Academy of Pharmacy, where he heads the AI think tank. He is the author of two books for the general public: ""The AI Revolution in Medicine"" and ""Smart Medicines: Healing Tomorrow with Artificial Intelligence"" (DBS-Albin Michel Publishers)."